Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
The Journal of Infectious Diseases|March 23, 2017
Bumped-Kinase Inhibitors for Cryptosporidiosis TherapyMatthew A Hulverson, Sumiti Vinayak, Ryan Choi, et al.International Journal for Parasitology. Drugs and Drug Resistance|March 5, 2018
Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoitesRoberto Sánchez-Sánchez, Ignacio Ferre, Michela Re, et al.Plos Neglected Tropical Diseases|July 30, 2025
Anti-Cryptosporidium efficacy of BKI-1708, an inhibitor of Cryptosporidium calcium-dependent protein kinase 1Ryan Choi, Matthew A Hulverson, Deborah A Schaefer, et al.The Journal of Infectious Diseases|October 15, 2013
A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validationKayode K Ojo, Richard T Eastman, Ramasubbarao Vidadala, et al.Antimicrobial Agents and Chemotherapy|March 15, 2023
Comparison of Toxicities among Different Bumped Kinase Inhibitor Analogs for Treatment of CryptosporidiosisMatthew A Hulverson, Ryan Choi, Deborah A Schaefer, et al.Journal of Medicinal Chemistry|June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of ToxoplasmosisRama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.ACS Medicinal Chemistry Letters|December 23, 2015
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of Toxoplasma gondii CDPK1Wenlin Huang, Kayode K Ojo, Zhongsheng Zhang, et al.Veterinary Parasitology|January 8, 2021
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseasesWesley C Van Voorhis, Matthew A Hulverson, Ryan Choi, et al.ACS Infectious Diseases|November 1, 2016
Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetaseStephen Nakazawa Hewitt, David M Dranow, Benjamin G Horst, et al.International Journal for Parasitology|September 14, 2017
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosisMatthew A Hulverson, Ryan Choi, Samuel L M Arnold, et al.Pageof 7